Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
November 22, 2024: Researches Push For More Studies on Trulicity and Other GLP-1 Drugs and Cancer Risks A study published in the journal Endocrine Connections urged the scientific community to examine whether or not GLP-1 drugs, like Trulicity, could increase the risk of someone developing thyroid cancer
Helicobacter pylori eradication in parkinsons disease: a randomized placebo-controlled trial
Science 385 , eadj1182 (2024)
States have likely pulled back on AOM coverage due to the unprecedented adoption of GLP-1s, which triggered sharp increases in pharmaceutical spending
References SURMOUNT-5 head-to-head trial (NEJM, May 2025) summary via American College of Cardiology: SURPASS-2 primary publication (NEJM, 2021): Eli Lilly SURMOUNT-1 results announcement (NEJM data): Insights into the Mechanism of Action of Tirzepatide (PMC narrative review): Tirzepatide is an imbalanced and biased dual GIP/GLP-1 receptor agonist (PMC): SURMOUNT-5 GI tolerability / discontinuation data (Applied Clinical Trials, tctmd, DiabetesontheNet coverage): SURMOUNT-1 to -4 GI tolerability (Rubino 2025, Diabetes Obesity & Metabolism): Community sentiment context Reddit GLP-1 side-effect analysis and comparative meta-analyses (PMC): Research Use Only Notice: The content on this page is provided for informational and educational purposes only
Laser and Lights Paradoxical hair growth after using lasers and lights for hair removal has triggered interest in using these devices as a treatment modality
US$ 22.74
US$ 25.41
US$ 20.12
US$ 28.64
US$ 20.82
